Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

4,932.00p
   
  • Change Today:
      64.00p
  • 52 Week High: 6,070.00p
  • 52 Week Low: 3,952.00p
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 7,424
  • Market Cap: £3,243.65m
  • RiskGrade: 128
  • Beta: 0.70

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Continuing Operations          
Revenue 285.70 270.70 238.80 238.60 222.10
Operating Profit/(Loss) 35.50 28.10 (6.30) 14.30 10.00
Profit Before Tax 38.70 30.40 (6.80) 14.30 11.40
Profit After Tax 30.30 24.10 (7.10) 42.60 8.80
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 30.30 24.10 (7.10) 42.60 8.80
           
Continuing EPS          
Earnings per Share - Basic 48.40p 36.50p (11.70p) 69.00p 13.30p
Earnings per Share - Diluted 48.00p 36.30p (11.00p) 67.80p 13.10p
Earnings per Share - Adjusted 57.30p 43.50p 35.80p 40.90p 30.50p
Continuing and Discontinued EPS          
Earnings per Share - Basic 48.40p 36.50p (11.70p) 69.00p 13.30p
Earnings per Share - Diluted 48.00p 36.30p (11.00p) 67.80p 13.10p
Earnings per Share - Adjusted 57.30p 43.50p 35.80p 40.90p 30.50p
Dividend per Share 10.30p 9.40p 8.90p 8.10p 7.40p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-17 31-Dec-16
Total Non-Current Assets 612.80 607.30 615.00 552.70 578.60
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 841.70 818.50 802.80 775.00 811.00
Total Liabilities 343.60 338.60 314.40 351.80 415.00
Net Assets 498.10 479.90 488.40 423.20 396.00
           
Shareholders Funds 500.40 481.00 486.10 419.10 399.50
Minority Interests/Other Equity (2.30) (1.10) 2.30 4.10 (3.50)
Total Equity 498.10 479.90 488.40 423.20 396.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page